enarfrdehiitjakoptes

Pharma IPR Conference 2024

Pharma IPR Conference
From March 05, 2024 until March 07, 2024
Mumbai - The Westin Mumbai Garden City, Maharashtra, India
(Please double-check the dates and location on the official site below before attending.)
Categories: Medical & Pharma
Tags: Pharma

Pharma IPR India

About Pharma IPR Conference The Pharma IPR Conference is a unique event. Head of Patent Litigation. VP-Intellectual Property. Head of Legal/Legal Affaires. Who should be a partner? National and international law firms. IP Software Companies. Legal/IP Consultants Patent Search Companies Dr. Patnala Sri Ramachandra Murthy.

Informa Markets Division, Informa PLC. The Pharma IPR India website is part of Informa Markets Division.

This site is owned and operated by Informa PLC. All copyrights are theirs. The registered office of Informa PLC is located at 5 Howick Place in London SW1P1WG. Registered in England and Wales. Registration Number 8860726.

Pharma IPR India by Informa Markets is a conference that focuses on Intellectual Property Rights in the pharmaceutical industry. Informa Markets, a leader in B2B event production, is also the creator of CPHI - a global event for the pharmaceutical industry.

The only conference that is devoted to Intellectual Property in India's Pharmaceutical Industry, the Pharma IPR Conference. The 13th Annual Pharma IPR conference is scheduled to take place in Mumbai, from March 5-7 2024. The conference will bring together industry players to strategize effective IP management in order to protect valuable innovations within the pharma sector.

The conference will explore the challenges of IP protection and the emerging strategies for navigating them.

General Counsel and Senior Vice President (Legal & Compliance).

Hits: 2276

Register for tickets or booths

Please register at the official website of Pharma IPR Conference

Venue Map and Hotels Around

Mumbai - The Westin Mumbai Garden City, Maharashtra, India Mumbai - The Westin Mumbai Garden City, Maharashtra, India


Comments

800 Characters left